How to buy Evoke Pharma stock (EVOK)

Evoke Pharma is a drug manufacturers - specialty & generic business based in the US. Evoke Pharma shares (EVOK) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.96 – an increase of 12.73% over the previous week. Evoke Pharma employs 4 staff and has a trailing 12-month revenue of around $8.6 million.

Our top picks for where to buy Evoke Pharma stock

Buy Evoke Pharma stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Evoke Pharma stock price (NASDAQ: EVOK)

Use our graph to track the performance of EVOK stocks over time.

Evoke Pharma shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$4.96
52-week range	$3.54 - $14.04
50-day moving average more info button	$4.99
200-day moving average more info button	$5.64
Wall St. target price	$18.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-10.13

Is it a good time to buy Evoke Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Evoke Pharma price performance over time

Historical closes compared with the close of $5.07 from 2024-12-20

1 week (2024-12-17)	10.46%
1 month (2024-11-25)	16.55%
3 months (2024-09-24)	1.40%
6 months (2024-06-24)	803.74%

1 year (2023-12-22)	340.87%
2 years (2022-12-23)	-83.87%
3 years (2021-12-23)	90.72
5 years (2019-12-24)	224.64

Evoke Pharma financials

Revenue TTM	$8.6 million
Gross profit TTM	$2.1 million
Return on assets TTM	-33.5%
Return on equity TTM	-349.91%
Profit margin	-71.33%
Book value	$4.90
Market Capitalization more info button	$6.5 million

TTM: trailing 12 months

Evoke Pharma share dividends

We're not expecting Evoke Pharma to pay a dividend over the next 12 months.

Have Evoke Pharma's shares ever split?

Evoke Pharma's shares were split on a 1:12 basis on 31 July 2024 . So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Evoke Pharma shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Evoke Pharma shares which in turn could have impacted Evoke Pharma's share price.

Evoke Pharma share price volatility

Over the last 12 months, Evoke Pharma's shares have ranged in value from as little as $3.54 up to $14.0388. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evoke Pharma's is 0.348. This would suggest that Evoke Pharma's shares are less volatile than average (for this exchange).

Evoke Pharma overview

Evoke Pharma, Inc. , a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California. .

Frequently asked questions

null
What percentage of Evoke Pharma is owned by insiders or institutions?
Currently 4.585% of Evoke Pharma shares are held by insiders and 17.125% by institutions. How many people work for Evoke Pharma?
Latest data suggests 4 work at Evoke Pharma. When does the fiscal year end for Evoke Pharma?
Evoke Pharma's fiscal year ends in December. Where is Evoke Pharma based?
Evoke Pharma's address is: 420 Stevens Avenue, Solana Beach, CA, United States, 92075 What is Evoke Pharma's ISIN number?
Evoke Pharma's international securities identification number is: US30049G2030 What is Evoke Pharma's CUSIP number?
Evoke Pharma's Committee on Uniform Securities Identification Procedures number is: 30049G104